BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34635145)

  • 1. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
    Ohmoto A; Sato Y; Asaka R; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takeuchi K; Mori S; Takahashi S
    Mod Pathol; 2021 Nov; 34(11):1979-1989. PubMed ID: 34247193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postirradiated neuroendocrine carcinoma of the sinonasal tract.
    Wang CP; Hsieh CY; Chang YL; Lou PJ; Yang TL; Ting LL; Ko JY
    Laryngoscope; 2008 May; 118(5):804-9. PubMed ID: 18520182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
    Jo VY; Krane JF; Pantanowitz L; Monaco SE
    Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma.
    Chen CL; Hsu MM
    Hum Pathol; 2000 Feb; 31(2):227-32. PubMed ID: 10685638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
    Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
    J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
    Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
    Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine carcinomas of the head and neck: A small case series.
    Mitchell MB; Kimura K; Chapurin N; Saab Chalhoub M; Mehrad M; Langerman A; Mannion K; Netterville J; Rohde S; Sinard R; Kim Y
    Am J Otolaryngol; 2021; 42(4):102992. PubMed ID: 33640803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
    Yachida S; Vakiani E; White CM; Zhong Y; Saunders T; Morgan R; de Wilde RF; Maitra A; Hicks J; Demarzo AM; Shi C; Sharma R; Laheru D; Edil BH; Wolfgang CL; Schulick RD; Hruban RH; Tang LH; Klimstra DS; Iacobuzio-Donahue CA
    Am J Surg Pathol; 2012 Feb; 36(2):173-84. PubMed ID: 22251937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
    Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
    BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations of GI-NECs involving three main signaling pathways.
    Dai Q; Zhang J; Long W; Haybaeck J; Yang Z
    Cancer Med; 2023 Apr; 12(7):8238-8250. PubMed ID: 36653904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced sarcoma of head and neck: 50 years of experience at a single institution in an endemic area of nasopharyngeal carcinoma in China.
    Wei Z; Xie Y; Xu J; Luo Y; Chen F; Yang Y; Huang Q; Tang A; Huang G
    Med Oncol; 2012 Jun; 29(2):670-6. PubMed ID: 21259056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 Gene Mutation Identified by Next Generation Sequencing in Poorly Differentiated Neuroendocrine Carcinoma of the Nasal Cavity.
    Wasserman JK; AlGhamdi D; de Almeida JR; Stockley TL; Perez-Ordonez B
    Head Neck Pathol; 2019 Sep; 13(3):516-522. PubMed ID: 29845478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF
    Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
    Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?
    Hadoux J; Blanchard P; Scoazec JY; Burtin P; Planchard D; Malka D; Berdelou A; Boige V; Duvillard P; Leboulleux S; Faron M; Tselikas L; Deutsch E; Ducreux M; Baudin E
    Neuroendocrinology; 2021; 111(1-2):139-145. PubMed ID: 31639792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.
    Zhang P; Zhang L; Liu H; Zhao L; Li Y; Shen JX; Liu Q; Liu MZ; Xi M
    Cancer Res Treat; 2017 Jul; 49(3):695-705. PubMed ID: 27737535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of gastric neuroendocrine carcinomas.
    Ikegame K; Hatakeyama K; Terashima M; Sugino T; Aizawa D; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
    Eur J Surg Oncol; 2023 Sep; 49(9):106987. PubMed ID: 37463826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.